Search Results - G. Basile

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Flood and landslide warning based on rainfall thresholds and soil moisture indexes: the HEWS (Hydrohazards Early Warning System) for Sicily by G. Brigandì, G. T. Aronica, B. Bonaccorso, R. Gueli, G. Basile

    Published in Advances in Geosciences (2017-09-01)
    Get full text
    Article


  2. 2

    Robotic distal ureterectomy and ureteric reimplantation for low-grade distal urothelial carcinoma in a patient with severe CKD by M. Yao, H. Alzahrani, G. Basile, A. Shoniwa, P. Patki, F. Mumtaz, A. Bex, A. Reekhaye, R. Barod

    Published in European Urology Open Science (2025-09-01)
    Get full text
    Article


  3. 3

    Shaping Educator Preparation to Build a Stronger Education Workforce by Tanya Pinkerton, Carlyn Ludlow, Jordan M. O. Causadias, Wendy Peia Oakes, Nicole L. Thompson, Heather Villarruel, Carole G. Basile

    Published in Education Sciences (2025-05-01)
    Get full text
    Article


  4. 4

    3D-based budding score of renal masses selected for surgery: A novel application of 3D modelling for preoperative prediction of adverse pathological features by G. Basile, J. Leow, H. Alzahrani, M. Yao, N. Pavithran, F. Sordelli, P. Patki, F. Mumtaz, R. Barod, A. Reekhaye, A. Bex

    Published in European Urology Open Science (2025-09-01)
    Get full text
    Article


  5. 5

    1340 NDI-101150 is a potent and highly selective hematopoietic progenitor kinase 1 (HPK1) inhibitor that promotes a robust and broad anti-tumor immune response by Scott Daigle, David Ciccone, Samantha Carreiro, Christine Loh, Neelu Kaila, Fu-Shan Kuo, Scott Boiko, Gene Yau, Esha A Gangolli, Denise Levasseur, Bhaskar Srivastava, Frank G Basile

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  6. 6

    Emerging diabetes therapies: Bringing back the β-cells by G. Basile, M.M.F. Qadir, F. Mauvais-Jarvis, A. Vetere, V. Shoba, A.E. Modell, R.L. Pastori, H.A. Russ, B.K. Wagner, J. Dominguez-Bendala

    Published in Molecular Metabolism (2022-06-01)
    Get full text
    Article


  7. 7

    PB2099: A FIRST-IN-HUMAN PHASE 1 TRIAL OF NX-1607, A FIRST-IN-CLASS ORAL CBL-B INHIBITOR, IN PATIENTS WITH ADVANCED MALIGNANCIES INCLUDING RICHTER TRANSFORMATION DLBCL by A. Sharp, A. Williams, S. Blagden, R. Plummer, D. Hochhauser, M. G. Krebs, S. Pacey, J. Evans, S. Whelan, S. Nandakumar, S. Rogers, K. L. Jameson, F. G. Basile, J. de Bono, H.-T. Arkenau

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  8. 8

    751 Monotherapy results from an ongoing phase 1a dose escalation study of NDI-101150, a highly selective oral hematopoietic progenitor kinase 1 (HPK1) inhibitor by Scott Daigle, Sunil Sharma, Xinyan Zhang, Martin Gutierrez, Patricia Fraser, David Sommerhalder, Scott Boiko, Esha A Gangolli, Bhaskar Srivastava, Frank G Basile, Marcus Noel, Amanda Hoerres, Nawaid Rana, Rama Balaraman

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  9. 9

    Is whenever feasible-strategy for partial nephrectomy invariably justified? the impact of clinical tumour size on postoperative renal function by G. Fallara, A. Larcher, G. Rosiello, G. Basile, D. Cignoli, G. Colandrea, A. Martini, W. Cazzaniga, C.A. Bravi, M. Bandini, G. Baiamonte, A. Briganti, A. Salonia, R. Bertini, F. Montorsi, U. Capitanio

    Published in European Urology Open Science (2020-10-01)
    Get full text
    Article


  10. 10

    Neoadjuvant versus adjuvant chemotherapy for upper tract urothelial carcinoma: results from the national cancer database by G. Sorce, A. Martini, J. Pfail, U.G. Falgario, N. Waingankar, G. Gandaglia, N. Fossati, G. Fallara, F. Barletta, S. Scuderi, D. Robesti, D. Cannoletta, D. Cignoli, G. Basile, L. Nocera, G. Rosiello, E. Mazzone, C.A. Bravi, A. Necchi, F. Montorsi, A. Briganti, M.D. Galsky, J.P. Sfakianos

    Published in European Urology Open Science (2020-10-01)
    Get full text
    Article


Search Tools: